Zentalis Pharmaceuticals
Stock Forecast, Prediction & Price Target

Zentalis Pharmaceuticals Financial Estimates

Zentalis Pharmaceuticals Revenue Estimates

Zentalis Pharmaceuticals EBITDA Estimates

Zentalis Pharmaceuticals Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026 12/31/2027 12/31/2028
Revenue
 
% change YoY
$0
 
N/A
$0
 
0%
$0
 
0%
Avg: $1.60M
Low: $1.60M
High: $1.61M
avg. 0%
Avg: $19.00M
Low: $18.97M
High: $19.12M
avg. 1082.98%
Avg: $111.85M
Low: $111.69M
High: $112.58M
avg. 488.53%
Avg: $271.55M
Low: $271.16M
High: $273.32M
avg. 142.77%
Net Income
 
% change YoY
$-164.26M
 
N/A
$-220.83M
 
-34.43%
$-292.19M
 
-32.31%
Avg: $-297.05M
Low: $-267.52M
High: $-181.83M
avg. -1.66%
Avg: $-317.45M
Low: $-281.25M
High: $-144.55M
avg. -6.86%
Avg: $-162.73M
Low: $-164.11M
High: $-162.43M
avg. 48.73%
Avg: $-68.81M
Low: $-69.39M
High: $-68.68M
avg. 57.71%
EBITDA
 
% change YoY
$-268.52M
 
N/A
$-233.27M
 
13.12%
$-275.50M
 
-18.10%
Avg: $0
Low: $0
High: $0
avg. 100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
EPS
 
% change YoY
-$3.85
 
N/A
-$4.18
 
-8.57%
-$4.47
 
-6.93%
Avg: -$3.69
Low: -$4.09
High: -$2.78
avg. 17.55%
Avg: -$3.34
Low: -$4.3
High: -$2.21
avg. 9.35%
Avg: -$2.49
Low: -$2.51
High: -$2.48
avg. 25.51%
Avg: -$1.05
Low: -$1.06
High: -$1.05
avg. 57.71%
Operating Expenses
 
% change YoY
$216.54M
 
N/A
$227.28M
 
4.96%
$252.55M
 
11.11%
Avg: $0
Low: $0
High: $0
avg. -100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%

FAQ

What is Zentalis Pharmaceuticals stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 24.48% in 2025-2028.

We have gathered data from 9 analysts. Their low estimate is -267.52M, average is -297.05M and high is -181.83M.

What is Zentalis Pharmaceuticals stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 428.57% in 2025-2028.

We have gathered data from 6 analysts. Their low revenue estimate is $1.60M, average is $1.60M and high is $1.61M.

What is Zentalis Pharmaceuticals stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 27.53% in 2025-2028.

We have gathered data from 9 analysts. Their low earnings per share estimate is -$4.09, average is -$3.69 and high is $-2.78.

What is the best performing analyst?

In the last twelve months analysts have been covering Zentalis Pharmaceuticals stock. The most successful analyst is Matthew Harrison.